Regeneron Pharmaceuticals (0R2M.LSE) Q4 2013 Earnings

5NovConfirmed
Q1 1
Q3 2013
Q4 2013
0.79
2.27
3.75
5.23

Details

Expected EPS
N/A
Actual EPS
1.25
Surprise EPS
1.25
Surprise Percent
+∞%

Description

Regeneron Pharmaceuticals (0R2M.LSE) has reported earnings of 1.25 per share for Q4 2013.

0 Comments

Share your thoughts